A recent study published in Nature Machine Intelligence introduces an advanced artificial intelligence (AI) model capable of creating virtual...

SOUTH SAN FRANCISCO, Calif., Sept. 5, 2024. Rigel Pharmaceuticals, a commercial stage biotechnology company focused on hematologic disorders and...

NEW YORK, Sept. 4, 2024. Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

WEDNESDAY, Sept. 11, 2024 -- Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals,...

TUESDAY, Sept. 17, 2024 -- The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with...

A new study from researchers at Brighton and Sussex Medical School (BSMS), in the UK< reveals that patients living with certain long-term health...

September 8, 2024 -- Results from an exploratory analysis of the TROPION-Lung01 Phase III trial showed TROP2 as measured by AstraZeneca’s...

September 8, 2024 -- Results from an exploratory analysis of the TROPION-Lung01 Phase III trial showed TROP2 as measured by AstraZeneca’s...

Artificial intelligence revolutionizes gene mutation prediction in lung cancer, offering more accurate, faster insights for personalized treatment...

Pfizer’s experimental cancer weight loss drug helped patients regain weight in a mid-stage study giving fresh promise for the dangerous...